Skip to main content


Alexander Kabanov receives millions from NIH to develop effective therapeutics for triple-negative breast cancer

Alexander “Sasha” Kabanov, Ph.D., Dr.Sci., recently received funding from the National Institutes of Health’s National Cancer Institute to help combat triple-negative breast cancer, a disease that has fewer treatment options than other types of breast cancer. The four-year funding totaling … Read more

Tropsha, Muratov, partners identify potential drug candidates for COVID-19, land on National Institute of Environmental Health Sciences 2020 Papers of the Year list

The National Institute of Environmental Health Sciences (NIEHS) recently announced UNC Eshelman School of Pharmacy faculty paper “Computational modeling identifies drug candidates for SARS-CoV-2” as one of the organization’s 2020 Papers of the Year. The publication, with Alex Tropsha, Ph.D. and Eugene … Read more

Carolina Nanoformulation Workshop, Nanomedicine Drug Delivery Symposium tops 800 virtual participants, largest turnout in 18 years

The Carolina Nanoformulation Workshop and the Nanomedicine Drug Delivery Symposium (NanoDDS) combined to host the 2020 Virtual Carolina Nanoformulation Workshop & Nanomedicine Drug Delivery Symposium on September 14-16, 2020. BUILDING ON AN 18-YEAR LEGACY The one-day virtual NanoDDS symposium welcomed … Read more

T32 Carolina Cancer Nanotechnology Training Program renewed for another five years

Alexander “Sasha” Kabanov, Ph.D., Dr.Sci., recently received a five-year renewal of his T32 Carolina Cancer Nanotechnology Training Program (CCNTP), totaling more than $2.3 million in funding. The Carolina Cancer Nanotechnology Training Program is a 24-to 36-month National Cancer Institute–sponsored T32 … Read more

UNC Eshelman School of Pharmacy on the COVID-19 Frontlines

UNC Eshelman School of Pharmacy faculty, staff, students and alumni have come together while apart to serve patients in need during the COVID-19 pandemic. Researchers and labs are actively pursuing solutions to combat the COVID-19 virus, while students are finding … Read more

Ainslie receives NIH grant for influenza research

According to the Centers for Disease Control, the flu vaccine for the 2018-19 season was only 29 percent effective. Kristy Ainslie, Ph.D., wants to improve that number with the help of a $2.8 million grant. “All of us have been … Read more


Professor becomes first Russian-American scientist elected to Russian Academy of Sciences

Alexander “Sasha” V. Kabanov, Ph.D., Dr.Sc., M.A.E., FNAI, became interested in research at an early age. From his home in Moscow, he marveled at the work of his father, Viktor Kabanov, an award-winning polymer chemist and Chernobyl “liquidator,” whose advances in … Read more

Two UNC Ph.D. students are making cancer research accessible through blogging

For Sara Musetti and Manisit Das, Ph.D. students in the UNC Eshelman School of Pharmacy, their commitment to research doesn’t stop in the lab. Das and Musetti founded OncoBites, a blog that posts summaries of new developments in cancer research. … Read more


Propelling Into Success

In 2005, when Dr. Leaf Huang joined UNC Eshelman School of Pharmacy as chair of what is now Pharmaco Engineering and Molecular Pharmaceutics, the school wasn’t ranked in the top 10. So, Dr. Huang rolled up his sleeves and got to … Read more


The Tools To Change The World

Sam Lai, Ph.D., grew up in a privileged setting and thought the best way to show his appreciation was to become a doctor – until it wasn’t. “I’ve always felt that the two pillars in any society are health and … Read more

Eshelman Institute for Innovation awards $3.5 million across 24 research projects

On June 1, the Eshelman Institute for Innovation (EII) awarded $3.5 million across 24 projects to support research and education at the UNC Eshelman School of Pharmacy. The EII, created in 2014 with a $100 million gift from alumnus and … Read more

Shawn Hingtgen

Accelerate Brain Cancer Cure grants researchers $170,000

Goal to develop tumor-homing stem cell beacons for immune-based cancer therapy Shawn Hingtgen, Ph.D., Gianpietro Dotti, Ph.D., and Samir Mitragotri, Ph.D., had an idea – collaborate to create a cell therapy unlike any other to target hard-to-treat cancers. The three … Read more

Researchers study strategies for using nanotechnology to boost cancer therapeutics

University of North Carolina Lineberger Comprehensive Cancer Center researchers presented innovative new strategies for using tiny particles – particles the size of a DNA molecule or the width of a human hair – to boost cancer treatment as part of … Read more


Mucommune Receives Over $3M to Advance Muco-Trapping Antibodies

Mucommune LLC has been awarded over $3 million in five separate federal grants over the past several months to advance its muco-trapping antibody technology. The company was launched in 2016 by Sam Lai, Ph.D., an associate professor at the UNC … Read more

Huang, Kabanov and Roth Recognized for Research Influence

Three faculty members from the UNC Eshelman School of Pharmacy were recognized on the Clarivate Analytics list of Highly Cited Researchers for 2018. Leaf Huang, Ph.D., Alexander Kabanov, Ph.D., Dr.Sci., and Bryan Roth, Ph.D., M.D., were among 6,000 scientists worldwide … Read more

Kabanov Named President of Russian-American Scientists Association

Alexander Kabanov, Ph.D., Dr.Sci., assumed office as president of the Russian-American Scientists Association (RASA-America) on Nov. 5. Kabanov is the Mescal S. Ferguson Distinguished Professor and director of the Center for Nanotechnology in Drug Delivery at the UNC Eshelman School of Pharmacy and … Read more

Ainslie Awarded $1.89M NIH Grant to Develop Multiple Sclerosis Vaccine

The National Institutes of Health awarded a grant of nearly $2 million to Kristy Ainslie, Ph.D., for a proposal to develop a therapeutic vaccine for multiple sclerosis. Ainslie is an associate professor in the Division of Pharmacoengineering and Molecular Pharmaceutics … Read more

Hingtgen Awarded UNC Hettleman Prize for Young Faculty

Shawn Hingtgen, Ph.D., was awarded the Philip and Ruth Hettleman Prize for Artistic and Scholarly Achievement by Young Faculty by the University of North Carolina at Chapel Hill. Hingtgen is an associate professor at the UNC Eshelman School of Pharmacy … Read more

Stem Cells Show Promise as Drug Delivery Tool for Childhood Brain Cancer

The latest in a series of laboratory breakthroughs could lead to a more effective way to treat the most common brain cancer in children. Scientists from the UNC Eshelman School of Pharmacy and University of North Carolina Lineberger Comprehensive Cancer … Read more

CNDD’s Bahnson Receives SFRRI Young Investigator Award for Redox Biology Talk

Edward Bahnson, Ph.D., a member of the Center for Nanotechnology in Drug Delivery and an assistant professor of surgery at UNC School of Medicine, received a Young Investigator Award at the 19th biennial meeting of the Society for Free Radical … Read more

CNDD in the News

Brain-Derived Neurotrophic Factor Nanoformulation for Treating Neurological Diseases

Improved capture of cancer cells could aid in disease tracking

Nanotechnology Can Improve Safety, Effectiveness in Drug Delivery

Elizabeth Wayne interview